melatonin has been researched along with Leishmaniasis, Visceral in 1 studies
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parvez, S | 1 |
| Yadagiri, G | 1 |
| Arora, K | 1 |
| Javaid, A | 1 |
| Kushwaha, AK | 1 |
| Singh, OP | 1 |
| Sundar, S | 1 |
| Mudavath, SL | 1 |
1 other study available for melatonin and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Coalition of Biological Agent (Melatonin) With Chemotherapeutic Agent (Amphotericin B) for Combating Visceral Leishmaniasis via Oral Administration of Modified Solid Lipid Nanoparticles.
Topics: Administration, Oral; Amphotericin B; Animals; Biological Factors; Leishmania donovani; Leishmaniasi | 2023 |